Exposing the COVID19 Con Trick: 19 Studies Retracted So Far

Written by Retraction Watch (H/T Tom0mason) on . Posted in Current News

That excellent public service, retractionwatch.com has been work hard helping to expose the fake science behind the COVID-19 pandemic hoax. Below they list the 19 junk studies exposed and withdrawn so far. Watch this space for more pandemic fraud coming your way.

retractionwatch.com explains:

We’ve been tracking retractions of papers about COVID-19 as part of our database. Here’s a running list, which will be updated as needed. (For some context on these figures, see our letter in Accountability in Research.)

Retracted

  1. “Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,” bioRxiv preprint published January 31, 2020 and withdrawn February 2, 2020. More context here.
  2. “Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China,” medRxiv preprint published February 11, 2020 and withdrawn February 21, 2020. More context here.
  3. “Chinese medical staff request international medical assistance in fighting against COVID-19,” letter in The Lancet published February 24, 2020 and retracted February 26, 2020. More context here.
  4. “Potential False-Positive Rate Among the ‘Asymptomatic Infected Individuals’ in Close Contacts of COVID-19 Patients,” paper in the Chinese Journal of Epidemiology published March 5, 2020 and retracted a few days later. More context here.
  5. “An epidemiological investigation of 2019 novel coronavirus diseases through aerosol－borne transmission by public transport,” published in early March in Practical Preventive Medicine and retracted sometime in mid-April. More context here.
  6. “First viral replication of Covid-19 identified in the peritoneal dialysis fluid,” published in Bulletin de la Dialyse à Domicile on April 13, 2020, retracted on April 20, 2020. Our coverage here.
  7. “Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?” preprint published on medRxiv, May 11, 2020, withdrawn on May 20, 2020. Our coverage here.
  8. “From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends,” preprint posted on bioRxiv, January 25, 2020, withdrawn January 28, 2020.
  9. “Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease,” preprint posted on bioRxiv, April 12, 2020, withdrawn April 16, 2020.
  10. “Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2,” preprint posted on bioRxiv, April 5, 2020, withdrawn April 20, 2020.

See the full list at retractionwatch.com

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.

Share via

Trackback from your site.

Comments (2)

  • Avatar

    Roslyn Ross

    |

    And what if studies were retracted because they challenged the prevailing view? Were they wrong or just questioning.

    Reply

  • Avatar

    tom0mason

    |

    Just to update you, the total is now up at 30! ‘Temporarily retracted’ (whatever that means) total 3 and there is just one that has the label ‘Expressions of concern’

    1. “Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,” bioRxiv preprint published January 31, 2020 and withdrawn February 2, 2020.

    2. “Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China,” medRxiv preprint published February 11, 2020 and withdrawn February 21, 2020. More context here.

    3. “Chinese medical staff request international medical assistance in fighting against COVID-19,” letter in The Lancet published February 24, 2020 and retracted February 26, 2020. More context here.

    4. “Potential False-Positive Rate Among the ‘Asymptomatic Infected Individuals’ in Close Contacts of COVID-19 Patients,” paper in the Chinese Journal of Epidemiology published March 5, 2020 and retracted a few days later. More context here.

    5. “An epidemiological investigation of 2019 novel coronavirus diseases through aerosol－borne transmission by public transport,” published in early March in Practical Preventive Medicine and retracted sometime in mid-April. More context here.

    6. “First viral replication of Covid-19 identified in the peritoneal dialysis fluid,” published in Bulletin de la Dialyse à Domicile on April 13, 2020, retracted on April 20, 2020. Our coverage here.

    7. “Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?” preprint published on medRxiv, May 11, 2020, withdrawn on May 20, 2020. Our coverage here.

    8. “From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends,” preprint posted on bioRxiv, January 25, 2020, withdrawn January 28, 2020.

    9. “Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease,” preprint posted on bioRxiv, April 12, 2020, withdrawn April 16, 2020.

    10. “Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2,” preprint posted on bioRxiv, April 5, 2020, withdrawn April 20, 2020.

    11. “Mental health status and coping strategy of medical workers in China during The COVID-19 outbreak,” preprint posted on medRxiv, February 25, 2020, withdrawn March 7, 2020.

    12. “Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings,” published in Travel Medicine and Infectious Disease on April 11, 2020, retracted on May 2, 2020. Our coverage here.

    13. “Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients,” published on April 6, 2020 in the Annals of Internal Medicine, retracted on June 1, 2020.

    And on and on it goes…

    25. “Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?” published in The Lancet May 22, 2020, retracted and replaced July 9, 2020.

    26. “5G Technology and induction of coronavirus in skin cells,” published in Biological Regulators & Homeostatic Agents on July 16, 2020, withdrawn on July 24, 2020.

    27. “Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019.” medRxiv preprint posted May 6, 2020 and withdrawn June 20, 2020.

    28. “Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.” medRxiv preprint posted May 10, 2020 and withdrawn June 13, 2020.

    29. “Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort” medRxiv preprint posted May 26, 2020, and withdrawn June 21, 2020.

    30. “Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea” medRxiv preprint posted May 18, 2020, and withdrawn June 14, 2020.

    Please read https://retractionwatch.com/retracted-coronavirus-covid-19-papers/ for more information.
    And yes there is a few hydroxychloroquine retracted studies with the single ‘Expressions of concern’.

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via